Aileron Therapeutics, Inc. - Common Stock (NQ:ALRN)

2.110 UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 10, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Aileron Therapeutics, Inc. - Common Stock

< Previous 1 2 3 Next >

Aileron Therapeutics' Investigational Drug Shows Encouraging Action In Lung Fibrosis ↗

November 13, 2024

Aileron Therapeutics' Phase 1b trial shows LTI-03 improved biomarkers and reduced SPD levels, indicating the potential to enhance lung function in IPF patients.

Via Benzinga

ALRN Stock Earnings: Aileron Therapeutics Misses EPS for Q2 2024 ↗

August 15, 2024

ALRN stock results show that Aileron Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

ALRN Stock Earnings: Aileron Therapeutics Reported Results for Q1 2024 ↗

May 15, 2024

Aileron Therapeutics just reported results for the first quarter of 2024.

Via InvestorPlace

Aileron Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights

May 15, 2024

From Aileron Therapeutics, Inc.

Via GlobeNewswire

Aileron Therapeutics to Present at Two Upcoming Investor Conferences

May 06, 2024

From Aileron Therapeutics, Inc.

Via GlobeNewswire

BioMedNewsBreaks — Aileron Therapeutics Inc. (NASDAQ: ALRN) Closes Underwritten Registered Direct Offering

May 06, 2024

Via Investor Brand Network

Aileron Therapeutics Announces Closing of Underwritten Registered Direct Offering of up to Approximately $40 Million

May 03, 2024

Includes initial funding of approximately $20 million, as well as the potential for additional proceeds of approximately $20 million from exercise of three-year warrants issued in offering

From Aileron Therapeutics, Inc.

Via GlobeNewswire

Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Market Under Nasdaq Rules of up to Approximately $40 Million

May 01, 2024

Includes initial funding of approximately $20 million, as well as the potential for additional proceeds of approximately $20 million from exercise of three-year warrants issued in offering

From Aileron Therapeutics, Inc.

Via GlobeNewswire

Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)

May 01, 2024

From Aileron Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 18, 2024

Via Benzinga

Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

April 18, 2024

Via Benzinga

Aileron Therapeutics Inc. (NASDAQ: ALRN) Leading the Way in Thursday Trading Based on Percentage Gain

April 18, 2024

Via Investor Brand Network

ALRN Stock Earnings: Aileron Therapeutics Reported Results for Q4 2023 ↗

April 16, 2024

Aileron Therapeutics just reported results for the fourth quarter of 2023.

Via InvestorPlace

Aileron Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

April 15, 2024

From Aileron Therapeutics, Inc.

Via GlobeNewswire

Aileron Therapeutics Announces CEO Transition

March 12, 2024

From Aileron Therapeutics, Inc.

Via GlobeNewswire

Aileron Therapeutics and Pulmonary Care Experts To Discuss the Potential Implications of LTI-03 for Idiopathic Pulmonary Fibrosis in Virtual Key Opinion Leader Event

February 15, 2024

Topline results from Phase 1b study of LTI-03, Aileron’s novel Caveolin-1-related peptide in development for the treatment of idiopathic pulmonary fibrosis, expected in the second quarter of 2024

From Aileron Therapeutics, Inc.

Via GlobeNewswire

Aileron Therapeutics to Host Key Opinion Leader Event on February 15, 2024

February 01, 2024

Panel discussion will highlight LTI-03, Aileron’s novel Caveolin-1-related peptide, for the treatment of idiopathic pulmonary fibrosis

From Aileron Therapeutics, Inc.

Via GlobeNewswire

Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 30, 2024

Shares of United Parcel Service, Inc. (NYSE: UPS) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter sales results and issued FY24 sales

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

January 23, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

January 12, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

January 12, 2024

We're starting out the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!

Via InvestorPlace

Why Quanex Building Products Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

December 15, 2023

Shares of Quanex Building Products Corporation (NYSE: NX) moved lower during Friday’s session after the company reported fourth-quarter financial results. Quanex Building Products shares fell 10.7% to...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

December 15, 2023

Via Benzinga

Why Getaround Shares Are Trading Higher By Around 86%; Here Are 20 Stocks Moving Premarket ↗

December 15, 2023

Shares of Getaround, Inc. (NYSE: GETR) rose sharply in pre-market trading after the company reported a year-over-year increase in third-quarter financial results.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 15, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

December 15, 2023

It's time to dive into the biggest pre-market stock movers for Friday morning as we check out the winners and losers today!

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

December 14, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 06, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

November 01, 2023

Via Benzinga

Top 5 Health Care Stocks That May Collapse In Q2 ↗

May 10, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.